Cook MyoSite and Veristat progress Phase 3 trial of cell therapy for women with chronic incontinence
Cook MyoSite and Veristat have reached a key enrolment milestone [...]
As debate continues over the cost and sustainability of GLP-1 [...]
New data presented at the Alzheimer’s Association International Conference 2025 [...]
Gesynta Pharma has announced the second closing of its Series [...]